2021年心力衰竭临床进展亮点采撷  

Highlights of clinical progress in heart failure in 2021

作　　者：张健[1] 黄峻[2] Zhang Jian;Huang Jun(Heart Failure Care Unit,Heart Failure Center,Fuwai Hospital,State Key Laboratory of Cardiovascular Disease,National Center for Cardiovascular Diseases,CAMS and PUMC,Beijing 100037,China;The First Affliliated Hospital with Nanjing Medical Unversity,Nanjing 210029,China)

机构地区：[1]北京协和医学院,中国医学科学院阜外医院,国家心血管病中心,心力衰竭中心,心衰重症监护病区,北京100037 [2]南京医科大学第一附属医院,南京210029

出　　处：《中华心力衰竭和心肌病杂志（中英文）》2022年第1期39-47,共9页Chinese Journal of Heart Failure and Cardiomyopathy

摘　　要：2021年心力衰竭(心衰)临床研究领域出现了一些新进展和新认识,本文将从中国心衰防治水平的提升,心衰重大临床研究的突破,心衰新理念的出现,以及心衰药物治疗的现状和未来4个方面介绍2021年心衰临床研究领域的进展。There was some progress and new insights in the field of clinical research in heart failure(HF)in 2021.Thus,this paper will review the progress in clinical research on HF from the 4 aspects as following,improvement in the prevention and treatment of HF in China,breakthrough in major clinical researches on HF,new ideas emerged in HF,current status and prospect of medication for HF.

关 键 词：心力衰竭 新进展 临床研究 医疗质量 质量评价 

分 类 号：R541.6[医药卫生—心血管疾病]